Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Stock Information for 22nd Century Group Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About 22nd Century Group Inc

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit
Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Aethlon Medical to Present at Virtual Investor Conferences in September
Innovation Driving Cancer's Solid Tumors Market
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.